Exercise Training in Patients with Chronic Heart Failure Promotes Restoration of High-Density Lipoprotein Functional Properties
Authors:
- Volker AdamsVAVolker Adams
- Christian BeslerCBChristian Besler
- Tina FischerTFTina Fischer
- Meliana RiwantoMRMeliana Riwanto
- Friederike NoackFNFriederike Noack
- Robert HöllriegelRHRobert Höllriegel
- Andreas OberbachAOAndreas Oberbach
- Nico JehmlichNico Jehmlich
- Uwe VölkerUVUwe Völker
- Ephraim B. WinzerEphraim B. Winzer
- Karsten LenkKLKarsten Lenk
- Rainer HambrechtRHRainer Hambrecht
- 6 December 2013
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 113 (12) , 1345-1355
Abstract
Rationale:: High-density lipoprotein (HDL) exerts endothelial-protective effects via stimulation of endothelial cell (EC) nitric oxide (NO) production. This function is impaired in patients with cardiovascular disease. Protective effects of exercise training (ET) on endothelial function have been demonstrated. Objective:: This study was performed to evaluate the impact of ET on HDL-mediated protective effects and the respective molecular pathways in patients with chronic heart failure (CHF). Methods and Results:: HDL was isolated from 16 healthy controls (HDL healthy ) and 16 patients with CHF-NYHA-III (HDL NYHA-IIIb ) before and after ET, as well as from 8 patients with CHF-NYHA-II (HDL NYHA-II ). ECs were incubated with HDL, and phosphorylation of eNOS-Ser 1177 , eNOS-Thr 495 , PKC-βII-Ser 660 , and p70S6K-Ser 411 was evaluated. HDL-bound malondialdehyde and HDL-induced NO production by EC were quantified. Endothelial function was assessed by flow-mediated dilatation. The proteome of HDL particles was profiled by shotgun LC-MS/MS. Incubation of EC with HDL NYHA-IIIb triggered a lower stimulation of phosphorylation at eNOS-Ser 1177 and a higher phosphorylation at eNOS-Thr 495 when compared with HDL healthy . This was associated with lower NO production of EC. In addition, an elevated activation of p70S6K, PKC-βII by HDL NYHA-IIIb , and a higher amount of malondialdehyde bound to HDL NYHA-IIIb compared with HDL healthy was measured. In healthy individuals, ET had no effect on HDL function, whereas ET of CHF-NYHA-IIIb significantly improved HDL function. A correlation between changes in HDL-induced NO production and flow-mediated dilatation improvement by ET was evident. Conclusions:: These results demonstrate that HDL function is impaired in CHF and that ET improved the HDL-mediated vascular effects. This may be one mechanism how ET exerts beneficial effects in CHF.Keywords
This publication has 36 references indexed in Scilit:
- Effects of Dalcetrapib in Patients with a Recent Acute Coronary SyndromeNew England Journal of Medicine, 2012
- A sensitive assay for ABCA1-mediated cholesterol efflux using BODIPY-cholesterolJournal of Lipid Research, 2011
- Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery diseaseJournal of Clinical Investigation, 2011
- Modifying Apolipoprotein A-I by Malondialdehyde, but Not by an Array of Other Reactive Carbonyls, Blocks Cholesterol Efflux by the ABCA1 PathwayJournal of Biological Chemistry, 2010
- Role of HDL, ABCA1, and ABCG1 Transporters in Cholesterol Efflux and Immune ResponsesArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Major Lipids, Apolipoproteins, and Risk of Vascular DiseaseJAMA, 2009
- The metabolism and anti-atherogenic properties of HDLJournal of Lipid Research, 2009
- Relationship of Paraoxonase 1 (PON1) Gene Polymorphisms and Functional Activity With Systemic Oxidative Stress and Cardiovascular RiskJAMA, 2008
- Exercise training improves ageing‐induced decrease in eNOS expression of the aortaActa Physiologica Scandinavica, 2003
- Malondialdehyde modification and copper-induced autooxidation of high-density lipoprotein decrease cholesterol efflux from human cultured fibroblastsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1992